Cargando…
Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death, and its biology remains poorly understood, especially in regards to the immunosuppression induced by immune checkpoints, such as Siglec-15. Most cancer treatments composed of immune checkpoint inhibitors...
Autores principales: | Ren, Yanyi, Lyu, Jiayi, Guo, Yaoguang, Yao, Yuan, Hu, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885264/ https://www.ncbi.nlm.nih.gov/pubmed/35237695 http://dx.doi.org/10.1155/2022/9557859 |
Ejemplares similares
-
Knockdown of the Long Noncoding RNA TUG1 Suppresses Retinoblastoma Progression by Disrupting the Epithelial–Mesenchymal Transition
por: Wang, Hongyi, et al.
Publicado: (2022) -
Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021) -
Targeting the FOXM1‐regulated long noncoding RNA TUG1 in osteosarcoma
por: Li, Yang, et al.
Publicado: (2018) -
Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022) -
Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
por: Fan, Meng-ke, et al.
Publicado: (2021)